June 24th, 2015

Sports Injury Prevention Programs Help Keep Kids Moving

With the school year coming to an end, more of our days are spent out on the soccer field or in right field. Unfortunately, with an increase in sports activity parents worry more about their children’s risk of sports injury. More than 2.6 million children and adolescents are treated in the emergency department each year for sports and recreation-related injuries.[1] In fact, children aged 15-17 experience the highest emergency room visits for sports injuries, many of which are preventable.[2] These injuries are not limited to contact sports; in fact as many as 70 percent of anterior cruciate ligament (ACL) knee injuries involve little or no contact with the other player.[3]

DS SafeKids

DePuy Synthes Mitek Sports Medicine has worked with sports medicine orthopedic practices and Safe Kids Worldwide™ for nearly a decade to host educational clinics throughout the country to keep kids moving. This program, called PASSION2PLAY™, educates parents, coaches and young athletes about the importance of preventing sports-related injuries through sponsored educational clinics featuring clinical experts as well as tips for proper warm-up routines, injury prevention strategies and when it might be necessary to seek appropriate medical attention for injuries.

The latest PASSION2PLAY event with Safe Kids Worldwide featured professional football player Rueben Randle, who joined local teens in Waldwick, New Jersey and shared his experience with sports injury in the NFL and the importance of stretching and warming up.

Read More

June 16th, 2015

Cancer and Clots: An Unrecognized and Under-Researched Patient Burden

By Paul Burton, MD, PhD, Vice President, Medical Affairs, Janssen

More than one-third of all men and women in the United States will be diagnosed with cancer over the course of their lives. Living with cancer, the treatments and their side effects are significant burdens on their own. What many people with cancer often don’t realize is they are up to five times more likely to develop life-threatening blood clots than people the same age without cancer. These clots can occur deep in the veins in many parts of the body and sometimes travel to the lungs, a condition called venous thromboembolism (VTE). This risk is even more pronounced when patients with cancer undergo chemotherapy.

Blood clots are the second-leading cause of death in patients with cancer. We need a better understanding of how we can treat and prevent them, particularly for a large number of the one million patients who are treating their cancer outside the hospital.

That’s why the Janssen Pharmaceutical Companies of Johnson & Johnson, in conjunction with Bayer HealthCare, are furthering our commitment to addressing the most important unmet medical needs of our time by initiating a new research program: CALLISTO. CALLISTO is aimed at generating new evidence in the prevention and treatment of blood clots in patients with a wide range of cancer types.

Read More

June 5th, 2015

Domestic Violence: A Human Health Crisis

By Dr. Husseini Manji, Global Head, Neuroscience, Janssen Research & Development and Dr. Danielle Coppola, Senior Director, Compound Development Team, and Clinical Leader, Janssen Research & Development

Domestic Violence: A Human Health Crisis

When we talk about a public health care crisis, conversations often turn to serious illnesses like diabetes, cancer, and cardiovascular disease. But the growing body of evidence shows that domestic violence can be as devastating as the world’s most complex diseases.

The Centers for Disease Control and Prevention (CDC) lists domestic violence— sometimes referred to as “intimate partner violence” or IPV—as a “serious, preventable public health problem.” Domestic violence affects individuals and families and places a heavy burden on communities, law enforcement, and health care systems. In the United States alone:

  • Twenty-four people per minute are victims of physical violence by an intimate partner.1 In one study, 53 percent of men and 69 percent of women said they had experienced some form of intimate partner violence before the age of 25.2
  • Women ages 16 to 24 are four times more likely than the general population to be victims of partner violence.3
  • Up to 70 percent of men who abuse their partners also sexually or physically abuse their children.4
  • Medical costs associated with intimate partner violence are estimated at $5.8 billion each year.

Read More

June 4th, 2015

Leading the Way in Orthopaedics Innovation

By Martin Fitchet, M.D., Global Head, Research & Development, DePuy Synthes Companies of Johnson & Johnson

Martin Fitchett

On Thursday, a groundbreaking new era in orthopaedic innovation was launched for the DePuy Synthes Companies of Johnson & Johnson. I had the privilege to join my colleagues and distinguished guests, including Dr Mark Treherne, Chief Executive, UK Trade & Investment for the Life Sciences Organization, for the official opening of the newly redeveloped DePuy Synthes Beeston campus, based in Leeds, United Kingdom (UK). Our Beeston site has undergone extensive redevelopment to establish a leading global facility for Research & Development (R&D) in the field of orthopaedics.

I am incredibly proud to be a part of this exciting new chapter for DePuy Synthes. Our company is the largest, most comprehensive orthopaedics and neuro business that offers an unparalleled breadth of innovations to help advance the health and well-being of people around the world.

When it comes to advancements in orthopaedics, innovation is critical. By expanding our capabilities through state-of-the-art facilities at the Beeston campus, our R&D team will be better able to foster innovation, creating solutions to meet the needs of our patients and customers, while nurturing local talent and providing a significant contribution to the local economy.

Read More

June 2nd, 2015

Now is the Time for Personal Care Products Safety Reform

By Jeff B. Smith, President, U.S. Skincare, Johnson & Johnson Family of Consumer Companies

Jeff B. Smith

It’s been more than 70 years since the United States last updated our laws regulating personal care products, which include products from baby shampoo to anti-wrinkle creams. We think you’ll agree that public health and safety laws passed in the late 1930s deserve to at least be revisited for accuracy and relevancy. It’s for that reason the Johnson & Johnson Family of Consumer Companies supports modernizing a law that will enhance the U.S. Food and Drug Administration’s (FDA) authority to regulate personal care products, helping to bring peace of mind to consumers across the United States.

The Johnson & Johnson Family of Consumer Companies supports the Personal Care Products Safety Act sponsored by Senators Diane Feinstein (D-CA) and Susan Collins (R-ME). We welcome the opportunity to work with Congress and the U.S. FDA to better serve consumers and we thank Senators Feinstein and Collins for their bipartisan leadership on this important issue.

For more on our position on the Personal Care Products Safety Act, see here.

In short, Johnson & Johnson is supporting legislation that willrequire the registration of manufacturing facilities for personal care products;

  • require industry to report adverse events to FDA;
  • standardize Good Manufacturing Practices (GMPs) for cosmetics and personal care products;
  • and grant the FDA mandatory recall authority.

Read More

June 1st, 2015

J&J Recognized for Environmental Excellence at CleanMed

By Al Iannuzzi, Ph. D., Senior Director, Environment, Health, Safety & Sustainability

May 12-14th, the health care industry came together in Portland, Oregon for CleanMed 2015 – the nation’s premiere conference for sustainability in health care. The message at this year’s conference was clear: Within the health care industry, there are opportunities abound to lead the way for positive impact. At Johnson & Johnson, we continue to work across our organization to drive more sustainable practices that respond to our customers’ needs and fulfill our Citizenship & Sustainability priorities to advance human health and well-being, help to safeguard the planet, and lead a dynamic and growing business responsibly.


As part of our efforts to advance sustainability in health care, we partnered with Practice Greenhealth to field a survey at CleanMed and glean insights from attendees on their facilities’ sustainability initiatives and challenges. Most notably for the future of our Medical Devices and Janssen businesses, the 277 survey respondents voiced there is room for improvement when it comes to the health care sector leveraging its purchasing power to buy more sustainable products and services – nearly 41 percent of respondents said the sector is doing “poorly” in this area, while 50 percent said the sector is doing a “good” job.

Read More

May 28th, 2015

A New Kind of Leadership: CEO Alex Gorsky Addresses JHU Carey Graduates

GorskyJHU2Johnson & Johnson Chairman and CEO Alex Gorsky gave this year’s commencement address at the Johns Hopkins Carey Business School, where he spoke about values-based leadership and advised the graduating class about how to find purpose in their lives.

“I believe we need a new kind of leader and a new kind of leadership,” he said.  “Business leadership has a role in and a responsibility for creating a better society.”  Gorsky also advised the students to “understand the basic importance of taking care of yourself and going the distance.”

“The careers you have ahead are a marathon, not a sprint,” he added.

Read the full text of Alex Gorsky’s speech here.

Read More

May 27th, 2015

Johnson & Johnson Study Shows 45.5 years as the “Tipping Point” for Adult Health

Prevention and Health Maintenance are Key

By Dr. Jennifer Turgiss, DrPH, Vice President of Behavior Science and Analytics at Johnson & Johnson Health and Wellness Solutions, Inc.

What do you think of when you hear the term “over the hill?” The American Heritage Dictionary of Idioms[1] defines it as “past one’s prime” and the term is used to describe the decline caused by aging. There is actually a science to studying where the pinnacle of that proverbial “hill” is—at what point do things start going downhill from a health perspective and most importantly, what can we do to postpone that trip “over the hill?”

At Johnson & Johnson Health & Wellness Solutions, Inc., our focus is on developing holistic health solutions that treat the whole individual. Behavioral scientists from our organization were part of a team that recently published a study in the journal PLOS ONE that has far-reaching implications for health maintenance and disease prevention in middle age. [Read the press release here.]

AvalancheThe research team tested a study sample of 55,550 adults enrolled in a healthcare program over a three -year period to test the hypothesis that there is a breakpoint during the adult life that separates a period of relatively good health with a period of increasing declining health.

Read More

May 19th, 2015


Janssen Recognizes World IBD Day

By Scott Plevy, M.D., Disease Area Stronghold Leader, Inflammatory Bowel Disease (IBD), and Sean Larkin, Disease Area Stronghold Commercial Leader, IBD, Janssen

 Today, May 19th, the Janssen Pharmaceutical Companies of Johnson & Johnson recognize World Inflammatory Bowel Disease (IBD) Day, an annual event to raise awareness and support the five million people living with Crohn’s disease and ulcerative colitis (UC).

At Janssen, we work each and every day to improve the lives of people living with Crohn’s disease and UC—a passion that’s inspired us for more than two decades.

Guided by the conviction that there are no limits to science, we recognize that, despite our successes, we can do more for patients. As innovators and collaborators, we are committed to treating, intercepting and, one day, curing IBD.

We hope that you support World IBD Day and join the conversation on Twitter and LinkedIn by sharing what a world free from IBD means to you using #aworldfreefrom.

ScottPlevyJNJScott Plevy, M.D., is Vice President, Disease Area Stronghold Leader, IBD, Immunology Therapeutic Area, Janssen Research & Development, LLC.



Sean Larkin - Immunology - Comm DAS Lead_jpgSean Larkin is Vice President, Disease Area Stronghold Commercial Leader, Pulmonary and IBD, Janssen Global Services, LLC.

Read More

May 15th, 2015

Johnson & Johnson Employees Honored by Operation Smile

Would you ever think that polishing shoes could make a life-changing difference for someone you’ve never met? Or playing chess? Or selling ice cream?

Johnson & Johnson employees have changed more than 100,000 children’s lives doing things just like those to raise money to benefit Operation Smile. And last night I had the tremendous privilege of representing our employees to accept the first-ever Global Impact Award from Operation Smile. This honor recognizes the many hours and boundless passion that our employees have brought to fundraising activities, volunteer projects and other initiatives to benefit Operation Smile and the children it serves.

In my 30+ years with Johnson & Johnson, I have never seen our employees so engaged in our shared effort to serve patients all over the world. Fulfilling our Johnson & Johnson Credo is a mission we all hold near and dear to our hearts. By supporting Operation Smile in its mission to provide safe surgical solutions to children born with cleft lip or cleft palate, they bring to life our Credo responsibility to our patients.

Every three minutes, a child enters the world with this deformity. Without treatment, these children may not get enough to eat. They often have speech problems.

Read More